Publication | Open Access
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
345
Citations
31
References
2013
Year
This study provides a rationale to test AZD3965 in patients with SCLC. Our results suggest that patients with tumors expressing MCT1 and lacking in MCT4 are most likely to respond.
| Year | Citations | |
|---|---|---|
Page 1
Page 1